61980 Federal Register / Vol. 70, No. 207 / Thursday, October 27, 2005 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Research Program Project Applications 

(P01s). 

Date: November 18, 2005. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Madera, 1310 New Hampshire 

Avenue, NW., Washington, DC 20019. 

Contact Person: Keith A. Mintzer, PhD, 

Scientific Review Administrator, Division of 

Extramural Affairs, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6701 Rockledge Drive, Room 7186, MSC 

7924, Bethesda, MD 20892. 301–435–0280. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 18, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–21414 Filed 10–26–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Member 

Conflict Meeting. 

Date: November 1, 2005. 

Time: 4 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Mark Swieter, PhD, Chief, 

Training and Special Projects Review Branch, 

Office of Extramural Affairs, National 

Institute on Drug Abuse, NIH, DHHS, 6101 

Executive Boulevard, Suite 220, Bethesda, 

MD 20892–8401, (301) 435–1389, 

ms80x@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Member 

Conflict Meeting. 

Date: November 1, 2005. 

Time: 5 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Mark Swieter, PhD, Chief, 

Training and Special Projects Review Branch, 

Office of Extramural Affairs, National 

Institute on Drug Abuse, NIH, DHHS, 6101 

Executive Boulevard, Suite 220, Bethesda, 

MD 20892–8401, (301) 435–1389, 

ms80x@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse Research 

Programs, National Institutes of Health, HHS) 

Dated: October 18, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–21415 Filed 10–26–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meeting 

Notice is hereby given of the second 

meeting of the NIH Public Access 

Working Group under the National 

Library of Medicine’s (NLM) Board of 

Regents. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The mission of the NIH Public Access 

Working Group is to advise the NLM 

Board of Regents on implementation of 

the new NIH Public Access Policy. This 

policy responds to strong Congressional 

interest in improving the public’s access 

to the published results of NIH-funded 

research. Under the policy, NIHsupported investigators are encouraged 

to submit manuscripts electronically to 

the National Library of Medicine’s 

PubMed Central (PMC). The PMC is the 

NIH digital repository of full-text, peerreviewed biomedical, behavioral, and 

clinical research journals. The policy 

included the establishment of this 

working group with representation from 

a broad range of interested stakeholders. 

The Working Group will: (1) Review 

statistical evidence on the impact of the 

policy, e.g., number of manuscripts 

submitted, summary data on embargo 

periods, connections to other NIH 

information resources, level of use, etc.; 

(2) provide suggestions for improving 

the implementation of the manuscript 

submission system and procedures; (3) 

assess the extent to which the policy is 

achieving its stated goals; and (4) 

suggest any changes to the policy that 

might further these goals. 

Name of Committee: NIH Public Access 

Working Group. 

Date: November 15, 2005. 

Time: 10 a.m. to 3 p.m. 

Agenda: NIH Public Access Policy 

Research and Discussion. 

Place: National Library of Medicine, 

Building 38, Board Room, 2nd Floor, 8600 

Rockville Pike, Bethesda, MD 20894. 

Contact Person: Donald A.B. Lindberg, 

M.D., Director, National Library of Medicine, 

National Institutes of Health, Building 38, 

Room 2E17, Bethesda, MD 20894, 301–496–

6221. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The comments should include 

the name, address, telephone number and, 

Federal Register / Vol. 70, No. 207 / Thursday, October 27, 2005 / Notices 61981 

when applicable, the business or professional 

affiliation of the interested person. 

Dated: October 18, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–21413 Filed 10–26–05; 8:45am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Molecular, 

Cellular, and Developmental Neurobiological 

Small Business Application Part II. 

Date: October 25, 2005. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott Downtown 

Silver Spring, 8506 Fenton Street, Silver 

Spring, MD 20910. 

Contact Person: Michael A. Lang, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4140, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1265, langm@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Topics in 

Virology. 

Date: October 26, 2005. 

Time: 7 p.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select, 480 King Street, 

Alexandria, VA 22314. 

Contact Person: Joseph D. Mosca, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Mental Health, 6701 Rockledge Drive, Room 

5158, MSC 7808, Bethesda, MD 20892, (301) 

435–2344, moscajos@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Neuropathic 

Pain 2. 

Date: October 26, 2005. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Joseph G. Rudolph, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, (301) 435–

2212, josephru@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Oxidative 

Stress in Cancer. 

Date: October 27, 2005. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Eun Ah Cho, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6202, 

MSC 7804, Bethesda, MD 20892, (301) 451–

4467, choe@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cognition 

and Perception Reviews. 

Date: October 28, 2005. 

Time: 8 a.m. to 10 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Hotel Rouge, 1315 16th St. NW., 

Washington, DC 20036. 

Contact Person: Dana Jeffrey Plude, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7848, Bethesda, MD 20892, 301–435–

2309, pluded@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Genomic 

Analysis of Amplicon Structure. 

Date: October 28, 2005. 

Time: 4:30 p.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Eva Petrakova, PhD, MPH, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6158, 

MSC 7804, Bethesda, MD 20892, 301–435–

1716, petrakoe@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict in Mechanisms of Emotion, Stress 

and Health. 

Date: October 28, 2005. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Dana Jeffrey Plude, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7848, Bethesda, MD 20892, 301–435–

2309, pludedcsr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, BDCN–

F15(B) Pharmacology and Diagnostics SBIR. 

Date: November 1, 2005. 

Time: 8:30 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Jerome Wujek, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5194, 

MSC 7846, Bethesda, MD 20892, (301) 435–

2507, wujekjer@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Pregnancy. 

Date: November 1, 2005. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Dennis Leszczynski, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6170, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1044, leszczyd@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Bioengineering. 

Date: November 1, 2005. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals.